The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2023

Filed:

Jun. 12, 2018
Applicant:

The University of North Carolina AT Chapel Hill, Chapel Hill, NC (US);

Inventors:

Lola M. Reid, Chapel Hill, NC (US);

Wencheng Zhang, Chapel Hill, NC (US);

Eliane Wauthier, Chapel Hill, NC (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/38 (2006.01); A61L 27/52 (2006.01); A61L 27/58 (2006.01); A61L 27/20 (2006.01); A61L 27/26 (2006.01); C12N 5/071 (2010.01); C12N 5/0775 (2010.01); A61L 27/56 (2006.01); A61L 27/36 (2006.01); A61L 27/34 (2006.01); A61L 27/22 (2006.01);
U.S. Cl.
CPC ...
A61L 27/3886 (2013.01); A61L 27/20 (2013.01); A61L 27/227 (2013.01); A61L 27/26 (2013.01); A61L 27/34 (2013.01); A61L 27/3604 (2013.01); A61L 27/3641 (2013.01); A61L 27/3813 (2013.01); A61L 27/3834 (2013.01); A61L 27/3839 (2013.01); A61L 27/52 (2013.01); A61L 27/56 (2013.01); A61L 27/58 (2013.01); C12N 5/067 (2013.01); C12N 5/0662 (2013.01); C12N 5/0668 (2013.01); C12N 5/0676 (2013.01); A61L 2430/26 (2013.01); C12N 2506/1346 (2013.01);
Abstract

Compositions and methods of transplanting cells by grafting strategies into solid organs (especially internal organs) are provided. These methods and compositions can be used to repair diseased organs or to establish models of disease states in experimental hosts. The method involves attachment onto the surface of a tissue or organ, a patch graft, a 'bandaid-like' covering, containing epithelial cells with supporting early lineage stage mesenchymal cells. The cells are incorporated into soft gel-forming biomaterials prepared under serum-free, defined conditions comprised of nutrients, lipids, vitamins, and regulatory signals that collectively support stemness of the donor cells. The graft is covered with a biodegradable, biocompatible, bioresorbable backing used to affix the graft to the target site. The cells in the graft migrate into and throughout the tissue such that within a couple of weeks they are uniformly dispersed within the recipient (host) tissue. The mechanisms by which engraftment and integration of donor cells into the organ or tissue involve multiple membrane-associated and secreted forms of MMPs.


Find Patent Forward Citations

Loading…